Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 948
Countries 149
Faculty 444
Health Topics 146

Filter from the selections below

Clear All Filters

Inhaled drug for MDR and XDR TB

We are progressing a new drug candidate to clinical trials to treat drug resistant TB and non-tuberculosis Mycobacteria. The drug shows promise in ex vivo and in vivo models and has received orphan drug designation by the US FDA. With our global partners we have progressed through GLP toxicology and are moving to phase 1 clinical trials in humans.

Active Dates 
01/01/2021 to 08/13/2021
Faculty Involved